InsidersTradesSigma
Track the Indegene share price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €139.8bn. The latest transaction was filed on 28 August 2026 (Disposal). Among the most active insiders: BPC Genesis Fund I- A SPV Ltd. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Indegene is a company specializing in digital health solutions and marketing services for pharmaceutical and biopharmaceutical companies. It offers services ranging from strategy to execution, integrating advanced technologies.